Clinical Trial Update: Early Bactericidal Activity of Rifampin + Meropenem + Amoxicillin/Clavulanate in Adults With Pulmonary TB [Phase 2]

View source ↗

Summary

Phase 2 trial assessing early bactericidal activity of a rifampin-meropenem-amoxicillin/clavulanate combination in adults with pulmonary tuberculosis; study com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis
• Tuberculosis

Drugs mentioned

• Meropenem (Meropenem)
• RIFAMPIN (RIFAMPIN)
• amoxicillin-clavulanate (amoxicillin-clavulanate)

Snippet

Sponsor: Johns Hopkins University | Conditions: Tuberculosis, Pulmonary | Phase 2 | Status: COMPLETED | Results posted: 2023-07-19